Efficacy and Safety of Drug-Eluting Bead TACE in the Treatment of Primary or Secondary Liver Cancer
CONCLUSIONS: DEB-TACE has a promising effect in the treatment of primary or secondary liver cancer. The treatment-related adverse reactions are tolerable.PMID:37153689 | PMC:PMC10156455 | DOI:10.1155/2023/5492931
Source: Canadian Journal of Gastroenterology - Category: Gastroenterology Authors: Jiabing Wang Haoqian Xu Ying Wang Long Feng Fengming Yi Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Gastroenterology | Liver | Pain | Urology & Nephrology